← Back to home
Comparison · Analytics

DoseFinding vs giscoR

A side-by-side editorial comparison of DoseFinding and giscoR — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs giscoR: at a glance

FeatureDoseFindinggiscoR
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingeurostat, geospatial, ropensci, r-package
Last editorial update1h ago5h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is giscoR?

giscoR's 1.0 moved its dataset index into the cache, so new Eurostat releases arrive without a package update.

giscoR downloads Eurostat GISCO administrative and statistical geodata — countries, NUTS regions, LAUs, urban audit units — as sf objects. The 1.0.0 release in December 2025 rebuilt the package on httr2, preferred GeoPackage downloads, reorganised the cache into topic folders, and moved the dataset database itself into the cache so it can be refreshed independently. Releases since have been a cache-persistence fix, a configurable timeout and an internals refactor.

Read the full giscoR trajectory →

DoseFinding vs giscoR: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

G
giscoR
ANALYTICS
0.0

giscoR's 1.0 moved its dataset index into the cache, so new Eurostat releases arrive without a package update.

◆ Current state

giscoR downloads Eurostat GISCO administrative and statistical geodata — countries, NUTS regions, LAUs, urban audit units — as sf objects. The 1.0.0 release in December 2025 rebuilt the package on httr2, preferred GeoPackage downloads, reorganised the cache into topic folders, and moved the dataset database itself into the cache so it can be refreshed independently. Releases since have been a cache-persistence fix, a configurable timeout and an internals refactor.

◆ Where it's heading

The package is decoupling itself from Eurostat's publication calendar. Historically each new GISCO vintage required a release that bumped default years and rebuilt an internal dataset; after 1.0.0 a user can call gisco_get_cached_db(update_cache = TRUE) and reach new data without waiting. The follow-up releases are consistent with a project in consolidation — fixing the cache it just introduced, exposing a timeout for slow downloads, and tidying internals.

◆ Prediction

With the database now self-updating, expect releases to shift toward download reliability and new GISCO endpoints rather than annual dataset bumps; the timeout option in 1.1.0 suggests large downloads are the current pain point.

Alternatives to DoseFinding and giscoR

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or giscoR.

See all DoseFinding alternatives → · See all giscoR alternatives →

Recent activity from DoseFinding and giscoR

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1mo agogiscoRInternal refactor with faster mocked tests
  2. 4mo agogiscoRDownload timeout becomes configurable
  3. 6mo agogiscoRCache persistence fixed; urban audit defaults to 2024
  4. 7mo agogiscoR1.0 caches the dataset index so new vintages need no release
  5. 1y agoDoseFindingConditional and predictive power for interim analyses
  6. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  7. 1y agogiscoRSource filtering fixed in gisco_get_lau()
  8. 1y agogiscoR2024 datasets and year arguments for education and healthcare
  9. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  10. 2y agoDoseFindingCompliance update for R-devel
  11. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and giscoR?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and giscoR are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than giscoR?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and giscoR are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to giscoR?

Top giscoR alternatives in Analytics are ranked by recent ship velocity. Browse the "giscoR alternatives" section above for the current picks, or visit /alternatives/giscor for the full list with editorial commentary on each.